BMY BRISTOL MYERS SQUIBB CO Company Mergers 8-K Filing 2024 - Acquisition of Karuna Therapeutics Bristol-Myers Squibb Company completes acquisition of Karuna Therapeutics, Inc. for $330.00 per share in cash.Get access to all SEC 8-K filings of the BRISTOL MYERS SQUIBB CO